Paragonix Technologies designs, produces, and sells organ transportation devices that safeguard organs during the journey between donor and recipient patients. 

Our award-winning devices mitigate risk in an otherwise high stakes environment. The Paragonix SherpaPak systems incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection. 

A recent Consensus Statement from ISHLT on donor heart and lung procurement cites the Paragonix SherpaPak™ CTS as a new technology to prevent freezing and establishes a regulated standard in the procurement process—where there has otherwise been none.

Paragonix SherpaPak CTS is the only commercially available FDA cleared and CE marked transport device for heart transportation. In 2020, this device was recognized for excellence in design with the prestigious Red Dot Award in the Medical Devices and Technology category. 

Paragonix is also developing transport devices for the lung, pancreas, kidney, and liver designed to improve donor organ quality and extending donor organ transport time.